Article
Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.
Current treatment options in oncology - 1 Oct 2023
Davoudi Fatemeh, Moradi Afshin, Becker Therese M, Lock John G, Abbey Brian, Fontanarosa Davide, Haworth Annette, Clements Judith, Ecker Rupert C, Batra Jyotsna
Abstract excerpt
OPINION STATEMENT: Prostate cancer (PCa) is the second most diagnosed malignant neoplasm and is one of the leading causes of cancer-related death in men worldwide. Despite significant advances in screening and treatment of PCa, given the heterogeneity of this disease, optimal personalized therapeutic strategies remain limited. However, emerging predictive and prognostic biomarkers based on individual patient...
Topics
- Humans
- Male
- Prostatic Neoplasms
- Precision Medicine
- Biomarkers, Tumor
- Genomics
- Prognosis
- Phenotype
- Neoplasm Staging
- Disease Management